Form 4 for ACIU AC Immune SA
Accepted 2026-06-15 06:50:18 ET · period of report 2026-06-11 · accession 0001651625-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 06:50 | 2026-06-11 | ACIU | Zuegel Martin | Interim CEO, Dir | A - Grant | $0.00 | +33.1K | 71.4K | +87% | $0 |
| D | 2026-06-15 06:50 | 2026-06-11 | ACIU | Zuegel Martin | Interim CEO, Dir | A - Grant | $0.00 | +77.8K | 77.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Share | 2026-06-11 | A | A | 33,136 | $0.00 | 71,408 | D | — | — | (F1) On June 11, 2026, the Reporting Person received a restricted share unit grant of 33,136 units under the AC Immune SA 2016 Stock Option and Incentive Plan (SOIP). (F2) Comprised of 71,408 common shares underlying outstanding restricted share units. |
| 2 | Derivative | Share Option (right to buy) | 2026-06-11 | A | A | 77,778 | $0.00 | 77,778 | D | $2.62 · 2027-06-10 to 2036-06-10 | 77,778 Common Share | (F3) On June 11, 2026, the Reporting Person received share options with respect to 77,778 shares under the SOIP. The share options will fully vest on June 10, 2027. |